Brief: Organigram Q3 Revenue CAD 105.782 Million Vs. IBES Estimate CAD 98.8 Million
11/08/2026 11:01
BRIEF-Organigram Q3 Revenue CAD 105.782 Million Vs. IBES Estimate CAD 98.8 Million Aug 11 (Reuters) - Organigram Q3 adjusted EBITDA CAD 13.413 million.
- Q3 net income CAD 105.538 million
- Q3 gross revenue CAD 145.071 million
Recent news on Organigram Global
See all newsBrief: Organigram Global Expects Annualized Run-Rate Cost Savings Of $8 Million-$10 Million In Fiscal 2027
Canada's Organigram Q3 revenue beats on Sanity acquisition; CFO to exit
Brief: Organigram Q3 Revenue CAD 105.782 Million Vs. IBES Estimate CAD 98.8 Million
Brief: Organigram Provides Business Update Highlighting Initial Sanity Performance And Canadian Market Share
Canada cannabis producer Organigram's Q2 net revenue falls more than expected